News & Media
Dr. Di Zhao Named an AACR Annual Meeting 2025 NextGen Star
Dr. Di Zhao has been recognized as a , a prestigious honor that highlights her significant contributions to cancer research.
Interview with UroToday
Dr. Zhao was recently to discuss her team¡¯s published research on ¡°Immune checkpoint B7-H3 as a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies.¡±
Highlighted in UroToday
Dr. Zhao's recent publication in Science Translational Medicine, emphasizing the impact of the lab's work in advancing cancer therapies.
MD Anderson News Releases
The Zhao Lab¡¯s research has been featured in multiple MD Anderson news releases:
MD Anderson Research Highlights for May 10, 2023
MD Anderson Research Highlights for July 13, 2022